NAT2 and urinary bladder carcinoma: However, the NAT2 low acetylator phenotype increased the risk of developing bladder cancer (OR=3.14; 95% CI=0.61-16.13) and (OR=3.67; 95% CI=0.30-44.73) in both sexes respectively.